DVM Best Practices, Nov 1, 2003 - DVM
  • SEARCH:
DVM News
DVM Best Practices, Nov 1, 2003
Introduction
Degenerative Joint Disease
DVM Newsmagazine is proud to present our first issue of DVM Best Practices exclusively for the equine practitioner. This special issue is devoted to equine degenerative joint disease (DJD) and also explores the problems associated with treating the disease with bulk compounded drugs.
Joint Disease
Effectively diagnosing, treating equine degenerative joint disease
By C.W. McIlwraith, BVSc, PhD, DACVS
Dr. C. W. McIlwraith provides an overview on identifying and treating degenerative joint disease in horses.
Glycosaminoglycans
Using glycosaminoglycans for treating equine joint diseases
By Gary W. White, DVM
Glycosaminoglycans have helped veterinarians target therapies toward the underlying pathology of equine joint disease, says Dr. Gary W. White.
Legal or not?
Know laws, responsibility regarding legal pharmacy compounding
By Joe Bertone, DVM
Dr. Joseph J. Bertone explores they myriad of legal and ethical problems veterinarians face when using some compounded drugs.
Drug piracy
Quality, safety, efficacy compromised
By Joe Bertone, DVM
There are no guarantees when a veterinarian unkowingly picks up a bulk compounded , pirated drug, Dr. Joseph J. Bertone offers his insight.
The ethical debate
The ethical debate
By Bernard Rollin, PhD , Joe Bertone, DVM
Drs. Bernard Rollin and Joseph J. Bertone explore the ethical debate surrounding use of pirated products.
Click here